1. Home
  2. BSVN vs FBRX Comparison

BSVN vs FBRX Comparison

Compare BSVN & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank7 Corp.

BSVN

Bank7 Corp.

HOLD

Current Price

$44.65

Market Cap

384.9M

Sector

Finance

ML Signal

HOLD

Logo Forte Biosciences Inc.

FBRX

Forte Biosciences Inc.

HOLD

Current Price

$32.09

Market Cap

487.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSVN
FBRX
Founded
2004
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
384.9M
487.2M
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
BSVN
FBRX
Price
$44.65
$32.09
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$53.33
$67.00
AVG Volume (30 Days)
8.9K
382.1K
Earning Date
04-14-2026
05-14-2026
Dividend Yield
2.46%
N/A
EPS Growth
N/A
61.30
EPS
4.50
N/A
Revenue
N/A
$36,000.00
Revenue This Year
$4.59
N/A
Revenue Next Year
$7.19
N/A
P/E Ratio
$9.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$33.92
$4.91
52 Week High
$50.10
$35.80

Technical Indicators

Market Signals
Indicator
BSVN
FBRX
Relative Strength Index (RSI) 59.62 61.53
Support Level $42.53 $26.67
Resistance Level $43.22 $35.62
Average True Range (ATR) 0.81 3.43
MACD 0.42 0.89
Stochastic Oscillator 54.14 74.07

Price Performance

Historical Comparison
BSVN
FBRX

About BSVN Bank7 Corp.

Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Share on Social Networks: